FindTrial
Sign In

Study of Homoeopathic Treatment For Eczema

Efficacy of LM potency in cases of chronic eczema - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110756
Enrollment
50
Registered
2026-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: LM Potency Individualized Homoeopathic Medicine: Individualized Homoeopathic LM Potency Medicines Will Be Selected On The Basis Of Case Taking And Totality Of Symptoms. Medicine Will

Sponsors

Shailee Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients Aged Between 12 to 60 Years 2 Diagnosed Case Of Chronic Eczema (Duration More Than 6 Weeks) 3 Eczema Are Severity Index (EASI) Score Up To 21 (Mild To Moderate) 4 Willing To Give Informed Consent 5 Patient Who Have Undergone Appropriate Washout Period At Least 10 To 15 Days After Discouninuation Of Conventional Treatment

Exclusion criteria

Exclusion criteria: 1 Cases Along With Severe Irreversible Pathology And Autoimmune Disease 2 Patients With Serious Systemic Illness

Design outcomes

Primary

MeasureTime frame
Reduction In Eczema Area Severity Index(EASI) Score Indicating Clinical ImprovementTimepoint: Baseline, 4 Weeks, 8 Weeks, 12 Weeks And Follow up At 24 Weeks.—

Secondary

MeasureTime frame
Percentage Of Improvement In Symptoms And Relapse RateTimepoint: Baseline, Monthly Follow up And Final Assessment After 18 Months.—

Countries

India

Contacts

Public ContactDr Jatin Dhagat

Shree Swaminarayan Homoeopathy College

drjatindhagat@gmail.com9426512506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026